Qube Research & Technologies (QRT)’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,033
Closed -$11.4K – 4016
2026
Q2
$11.4K Sell
10,033
-933
-9% -$1.14K ﹤0.01% 3274
2026
Q1
$13.8K Sell
10,966
-4,459
-29% -$5.63K ﹤0.01% 3308
2025
Q4
$18.8K Sell
15,425
-34,090
-69% -$51.2K ﹤0.01% 3390
2025
Q3
$73.3K Sell
49,515
-102,147
-67% -$156K ﹤0.01% 3117
2025
Q2
$176K Buy
+151,662
New +$214K ﹤0.01% 2935
2023
Q3
– Sell
-74,025
Closed -$1.34M – 4280
2023
Q2
$1.34M Sell
74,025
-101,850
-58% -$2.41M ﹤0.01% 1188
2023
Q1
$4.68M Buy
175,875
+98,805
+128% +$2.81M 0.02% 695
2022
Q4
$1.49M Buy
77,070
+50,169
+186% +$1.05M 0.01% 1051
2022
Q3
$562K Buy
26,901
+13,442
+100% +$257K ﹤0.01% 1426
2022
Q2
$108K Buy
+13,459
New +$86.2K ﹤0.01% 1921

Other funds holding PLRX

Qube Research & Technologies (QRT)'s PLRX Position: Q3 2026 in Review

Qube Research & Technologies (QRT) sold out of Pliant Therapeutics (PLRX) in Q3 2026, closing a stake of 10,033 shares — an estimated $11.4K sold.

Qube Research & Technologies (QRT) first reported a position in PLRX in Q2 2022 and held it in 10 quarters. The position peaked at $4.68M in Q1 2023. 84 funds tracked by Wall St. Rank hold PLRX as of Q3 2026.

  • Qube Research & Technologies (QRT) reported no remaining Pliant Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 10,033 Pliant Therapeutics shares in Q3 2026, an estimated $11.4K.
  • Qube Research & Technologies (QRT) first reported a position in Pliant Therapeutics in Q2 2022 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Pliant Therapeutics position peaked at $4.68M in Q1 2023.
  • 84 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.